Inmed Pharmaceuticals Inc (INM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,162 | -7,676 | -7,948 | -18,600 | -10,203 |
| Depreciation Amortization | 213 | 220 | 202 | 186 | 121 |
| Accounts receivable | -115 | -92 | -219 | -40 | 40 |
| Other Working Capital | -337 | -369 | -566 | -3,073 | -451 |
| Other Operating Activity | 634 | 932 | 1,247 | 5,944 | 702 |
| Operating Cash Flow | $-7,767 | $-6,986 | $-7,283 | $-15,584 | $-9,791 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -9 | -160 | -39 | -2 |
| Net Acquisitions | N/A | N/A | -500 | -209 | N/A |
| Other Investing Activity | 0 | 0 | -2 | -425 | 0 |
| Investing Cash Flow | $N/A | $-9 | $-662 | $-673 | $-2 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -291 | N/A |
| Common Stock Issued | 13,155 | 5,216 | 10,681 | 17,146 | 12,473 |
| Other Financing Activity | -884 | -562 | 0 | -1,785 | -1,618 |
| Financing Cash Flow | $12,271 | $4,654 | $10,681 | $15,071 | $10,855 |
| Exchange Rate Effect | N/A | N/A | N/A | N/A | 495 |
| Beginning Cash Position | 6,572 | 8,913 | 6,177 | 7,363 | 5,806 |
| End Cash Position | 11,076 | 6,572 | 8,913 | 6,177 | 7,363 |
| Net Cash Flow | $4,504 | $-2,341 | $2,736 | $-1,186 | $1,557 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,767 | -6,986 | -7,283 | -15,584 | -9,791 |
| Capital Expenditure | N/A | -9 | -160 | -39 | -2 |
| Free Cash Flow | -7,767 | -6,995 | -7,443 | -15,623 | -9,792 |